广东省进出口商品检验行政处罚办法（修正）
广东省人民政府
广东省进出口商品检验行政处罚办法（修正）
广东省人民政府
1994年9月30日粤府(1994)117号发布 根据1998年4月28日广东省人民政府令第36号广东省人民政府关于修改《广东省进出口商品检验行政处罚办法》的决定进行修正
第一条 根据《中华人民共和国进出口商品检验法》（以下简称《商检法》）和《中华人民共和国进出口商品检验法实施条例》（以下简称《商检法实施条例》）关于法律责任的有关规定，制定本办法。
第二条 广东进出口商品检验机构（以下简称商检机构）对本省区域内违反商检法规规定的行为，按本办法处理。但法律、法规另有规定的，从其规定。
第三条 下列行为属于违反《商检法》法定检验规定的行为：
（一）属于法定检验的进口商品到货后报关前不向商检机构办理登记或报验的；
（二）销售、使用未报经商检机构检验的属于法定检验进口商品的；
（三）出口未报经商检机构检验的属于法定检验出口商品的；
（四）属于法定检验的出口商品，经产地商检机构检验后须在口岸换证，但未报经口岸商检机构查验换证而出口的；
（五）使用未取得商检机构签发的适载合格证书或者经检验不合格的船舱、集装箱装运易腐烂变质的食品、冷冻品出口的；
（六）提供或者使用未经商检机构鉴定的包装容器出口危险货物的；
（七）其他逃避《商检法》法定检验行为的。
第四条 有第三条所列行为之一的，按照以下规定处罚：
（一）初犯并且所涉及的进出口商品总值在20万元以下的，给予通报批评、警告或者暂时停止接受报验，并可处以该商品总值1％以上、2％以下的罚款；
（二）重犯、情节严重或者所涉及的进出口商品总值在20万元以上的，给予通报批评、警告或者暂时停止接受报验，并处以该商品总值2％以上、5％以下的罚款。
第五条 下列行为属于违反商检强制管理的行为：
（一）销售、使用经商检机构检验不符合强制性标准或者其他必须执行的检验标准的进口商品的；
（二）出口经商检机构检验或者抽查检验不合格商品的；
（三）提供或者使用经商检机构鉴定不合格的包装容器包装出口危险货物的；
（四）擅自调换经商检机构检验合格的商品，或者改变其品质、规格、数量、重量、包装后出口的；
（五）擅自调换商检机构所抽取的样品，或者损毁、调换商检机构加施于样品上的标志、封识的；
（六）擅自调换、损毁商检机构加施于进出口商品及其包装上的商检标志及封识的；
（七）擅自损毁或者不按规定使用进出口商品质量认证标志的；
（八）编造、改变进出口商品的名称后报验，骗取有关商检证单的；
（九）向商检机构报验时，故意多报或者少报进出口商品的数量、重量超过10％，或者伪报商品总值超过10％，而不能提供正当理由的；
（十）申请商检机构签发有关产地证书时，不按规定如实申报其商品的原材料、组件的成份、来源以及其他必须如实申报情况的。
第六条 有第五条所列行为之一的，按以下规定处罚：
（一）初犯并且情节较轻的，给予通报批评、警告或者暂时停止接受报验，并可处以该商品总值5％以上、10％以下的罚款；
（二）重犯或者情节严重的，给予通报批评、警告或者暂时停止接受报验，并处以该商品总值10％以上、20％以下的罚款。
第七条 违反有关进出口商品的质量认证、质量许可、食品卫生注册登记等规定的，按照以下规定处罚：
（一）进口、销售、使用属于实施进口安全质量许可制度而未取得进口安全质量许可的商品，或者出口属于实施出口质量许可制度或者出口食品卫生注册登记制度而未取得出口质量许可或者未经出口食品卫生注册登记的商品的，给予警告、通报批评或者暂停接受报验，并可处以该商品
总值1％以上、5％以下的罚款；
（二）获准使用进出口质量认证标志或者取得进口安全质量许可、出口质量许可或者经出口食品卫生注册登记的企业，经检查不符合规定要求的，可暂停接受报验并责令其限期改进。经责令限期改进后，逾期仍不符合规定要求的，取消其使用认证标志的资格或者撤销其进口安全质量许
可、出口质量许可或者出口食品卫生注册登记；
（三）获得商检机构认可的检验机构，不按规定履行相应的义务或者经检查不符合规定要求的，可暂时停止其进出口商品检验、鉴定的业务并责令其限期改进，逾期仍不符合要求的，撤销其认可资格；
（四）未经国家商检局及其授权的商检机构批准、指定或者认可，擅自进行有关进出口商品检验、鉴定业务或者虽经批准但擅自扩大有关业务范围的，除责令其停止未经批准的检验、鉴定业务外，并可处其非法所得三倍以下的罚款；
第八条 获得商检机构认可或者注册的检验员或者报验员有违反商检规定行为的，暂时停止检验、报验业务，情节严重的撤销其认可或者注册资格。
第九条 商检机构对查证属实的假冒伪劣出口商品，可以监督销毁，并可对生产、经营单位处以该商品总值等值以下的罚款。
第十条 有伪造、变造、盗用商检机构的证单、印章、标志、封识和质量认证标志，或者买卖、涂改商检证单、标志行为的，按照以下规定对当事人进行处罚：
（一）其非法的证单、印章、标志或者封识尚未用于进出口的，处以5000元以上3万元以下的罚款；
（二）其非法的证单、印章、标志或者封识已经用于进出口的，处以有关商品总值等值以下的罚款。
情节严重，构成犯罪的，对直接责任人员依法追究刑事责任。
第十一条 当事人的行为同时违反商检法规的多项规定的，可以合并处罚。
第十二条 对违反商检法规行为的处罚，由有关商检机构的局长决定，但属下列情形之一的，必须报经广东商检局批准：
（一）罚款金额在10万元以上的；
（二）监督销毁的商品总值在10万元以上的，但该商品属于不立即销毁可能会对人身或者环境造成重大伤害或者污染的，可在销毁后3日内报告；
（三）停止接受报验30日以上的；
（四）撤销有关质量认证、质量许可、卫生注册登记、检验机构认可、检验员认可证书或者资格的；原证书如属于国家商检局批准颁发的，由广东商检局报国家商检局批准。
第十三条 商检机构查处违反商检法规的行为时，可以行使以下权利：
（一）向当事人或者知情人调查、询问；
（二）查阅、记录或者复制与案件有关的合同、票据、帐册、文件及其他资料；
（三）查看、拍摄与案件有关的物品、现场；
（四）责令当事人保全其违法行为所涉及的进出口商品，必要时，对有关的商品加施封识。
第十四条 商检机构对涉嫌伪造、变造、盗用、买卖或者涂改的商检证单、印章、标志或者封识，可以扣留。
第十五条 商检机构对本办法第七条第一项和第八条所列行为的查处，可以会同有关主管部门共同进行。
第十六条 依照本办法应受处罚的行为，在2年以后发现的，免于处罚。
第十七条 商检机构对违反商检法规的行为进行处罚，应当向当事人发出处罚决定书。
第十八条 受到罚款处罚的当事人应当自收到商检机构的处罚决定书之日起15日内向指定的银行缴纳罚款。
罚款全部上缴国库。
第十九条 当事人对商检机构的处罚不服的，可以自收到处罚决定书之日起30日内，向作出处罚的商检机构或者其上级商检机构申请复议。
有关商检机构应当在收到复议申请后10日内作出是否受理的决定，对不予受理的，应当将不予受理的理由和裁决通知当事人；对受理的，应当在收到复议申请后60日内作出复议决定并通知当事人。
第二十条 当事人对商检机构不受理复议的裁决不服或者对复议决定不服的，可以自收到不予受理裁决书之日起15日内，或者自收到复议决定书之日起30日内，向人民法院提起诉讼。
第二十一条 有下列情形之一的，由有关商检机构申请人民法院强制执行其作出的处罚或者复议决定：
（一）当事人收到处罚通知30日内不申请复议又不履行处罚决定的；
（二）当事人收到不受理复议裁决15日内不提起诉讼又不履行处罚决定的；
（三）当事人收到复议决定30日内不提起诉讼又不履行处罚决定的。
第二十二条 商检机构作出的处罚决定书、不受理复议裁决书和复议决定书，可以直接交当事人签收，也可以留置送达、邮寄送达，邮寄送达的以挂号回执上注明的日期为送达日期。无法送达的应当公告，公告30日即视为送达。
第二十三条 商检机构的工作人员滥用职权、徇私舞弊或者玩忽职守的，由其所在单位或者上级商检机构给予行政处分；情节严重，构成犯罪的，由司法机关依法追究其刑事责任。
第二十四条 本办法所指的金额以人民币计算。
第二十五条 处罚决定书、不受理复议裁决书和复议决定书的格式，由广东商检局统一制定。
第二十六条 本办法由广东商检局负责解释。
第二十七条 本办法自颁布之日起施行。
根据《中华人民共和国行政处罚法》、《广东省规章设定罚款限额规定》及其他有关法律法规的规定，广东省人民政府决定修改《广东省进出口商品检验行政处罚办法》，自1998年1月1日起施行。
《广东省进出口商品检验行政处罚办法》（省政府1994年9月30日以粤府〔1994〕117号文发布）作如下修改：
1．第三条第（一）项修改为：“属于法定检验的进口商品到货后报关前不向商检机构办理登记或报验的；”
删去第三条第（七）项。
2．第五条第（六）项修改为：“擅自调换、损毁商检机构加施于进出口商品及其包装上的商检标志及封识的；”
第五条第（七）项修改为：“擅自损毁或者不按规定使用进出口商品质量认证标志的；”
3．第七条第一句修改为：“违反有关进出口商品的质量认证、质量许可、食品卫生注册登记等规定的，按照以下规定处罚：”
第七条第（二）项修改为“获准使用进出口质量认证标志或者取得进口安全质量许可、出口质量许可或者经出口食品卫生注册登记的企业，经检查不符合规定要求的，可暂停接受报验并责令其限期改进。经责令限期改进后，逾期仍不符合规定要求的，取消其使用认证标志的资格或者撤
销其进口安全质量许可、出口质量许可或者出口食品卫生注册登记；”
第七条第（五）项单列一条并修改为：“第八条 获得商检机构认可或者注册的检验员或者报验员有违反商检规定行为的，暂时停止检验、报验业务，情节严重的撤销其认可或者注册资格。”
4．原第八条相应改为第九条，内容不变。
5．原第九条修改为：“第十条 有伪造、变造、盗用商检机构的证单、印章、标志、封识和质量认证标志，或者买卖、涂改商检证单、标志行为的，按照以下规定对当事人进行处罚：
（一）其非法的证单、印章、标志或者封识尚未用于进出口的，处以5000元以上3万元以下的罚款；
（二）其非法的证单、印章、标志或者封识已经用于进出口的，处以有关商品总值等值以下的罚款。
情节严重，构成犯罪的，对直接责任人员依法追究刑事责任。”
6．删去原第十条。
7．原第十六条修改为：“第十六条 依照本办法应受处罚的行为，在2年以后发现的，免于处罚。”
8．原第十八条修改为：“第十八条 受到罚款处罚的当事人应当自收到商检机构的处罚决定书之日起15日内向指定的银行缴纳罚款。
罚款全部上缴国库。”
1994年9月30日
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
State Food and Drug Administration General Administration of Customs of the People’s Republic of China
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
(SFDA Decree No. 25)
The Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim), adopted by the State Food and Drug Administration, the General Administration of Customs of the People’s Republic of China and the General Administration of Sport of China, is hereby promulgated in the decree sequence number of the State Food and Drug Administration and shall come into force as of September 1, 2006.
Shao Mingli
Commissioner
State Food and Drug Administration
Mou Xinsheng
Minister
General Administration of Customs of the People’s Republic of China
Liu Peng
Minister
General Administration of Sport of China
July 28, 2006
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
Article 1 The Provisions are formulated with a view to standardizing the administration of import and export of anabolic agents and peptide hormones in accordance with the Drug Administration Law of the People’s Republic of China, Customs Law of People's Republic of China, Anti-doping Regulations and other relevant laws and administrative regulations.
Article 2 The State adopts license control on the import and export of anabolic agents and peptide hormones.
Article 3 The importer shall apply for the importation of anabolic agents and peptide hormones to the State Food and Drug Administration.
Article 4 For the importation of anabolic agents and peptide hormones for medical purpose, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Copy of the Import Drug License (or the Pharmaceutical Product License) (original or duplicate);
(4) Copy of the Drug Supply Certificate, Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importer; to import drug substance and intermediate preparations including preparations to be repackaged in China for their own needs, drug manufacturers shall submit copies of the Drug Manufacturing Certificate, Corporate Business License and Organization Code Certificate;
(5) Where holders of the Import Drug License (or the Pharmaceutical Product License) entrust other companies to export their drugs, they shall provide the authorization letter for export.
All copies mentioned above should be stamped with the official seal of the importer.
Article 5 For the importation of anabolic agents and peptide hormones for teaching and scientific research purposes, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Certificates of legitimate qualifications of users in China, calculation basis for the quantity of the drug in use and letter of guarantee issued by the user for legitimate use and management of the drug;
(4) Approval documents for relevant scientific research projects or approval documents of relevant competent authority;
(5) Where entrusted by users for importation, importers shall provide copies of the authorization agreement, the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importers.
All copies mentioned above should be stamped with the official seal of the importer.
Article 6 Where a enterprise in China entrusted by an overseas enterprise for contract manufacturing needs to import anabolic agents and peptide hormones, it shall provide materials required in Items (1), (3) and (5) of Paragraph 1 of Article 5, in addition, official documents to prove recorded by the local (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government.
All copies mentioned above should be stamped with the official seal of the importer.
Article 7 The State Food and Drug Administration shall decide whether or not to approve the import within 15 working days after receiving the application for import and the relevant materials. Where the application is approved, the State Food and Drug Administration shall issue the Import License for the drug; where the application is not approved, the State Food and Drug Administration shall give reasons in writing.
Article 8 The importer may declare to the customs of the ports where drug importation is permitted upon presenting the Import License for the drug issued by the State Food and Drug Administration. The customs shall clear the drug in the presence of the Import License for the drug.
The Drug Import Note is not required for import of anabolic agents and peptide hormones.
Article 9 To import anabolic agents and peptide hormones including those sold in China for the first time for medical purpose, the importer shall fill in the Import Drug Clearance Form timely after going through the import formalities and submit the following materials in duplicate to the (food and) drug regulatory department where the port of entry is located, upon presenting the original Import Drug License (or the Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug, to apply for the Notice of Import Drug Port Test:
(1) Copies of the Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the Import License for the drug;
(2) Copies of the Drug Manufacturing Certificate or Drug Supply Certificate, and Copy of the Business License for Enterprises as a Legal Person.
(3) Copy of the certificate of origin;
(4) Copy of the purchasing contract;
(5) Copies of packing list, bill of lading and freight invoice;
(6) Copy of the certificate of analysis;
(7) Format of drug insert sheet, package and label (except for drug substance and intermediate preparation);
All copies mentioned above should be stamped with the official seal of the importer.
Article 10 After checking the received Import Drug Clearance Form and relevant materials, the port (food and) drug regulatory department shall return the original Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug to the importer, and send the Notice of Import Drug Port Test, along with a copy of the dossier as prescribed in Article 9 of the Provisions, to the port drug testing institute on the same day.
After receiving the Notice of Import Drug Port Test, the port drug testing institute shall contact the importer within two working days and conduct sampling on the storage site. Upon the completion of the sampling, the mark “sampled” shall be stamped on the back of the first page of the original Import License for the drug, with the seal of sampling institute affixed.
Article 11 Anabolic agents and peptide hormones imported for teaching and research purposes or for the domestic manufacturing contracted by overseas enterprises are exempted from testing.
Article 12 The port (food and) drug regulatory department shall report timely to the State Food and Drug Administration in any of the following circumstances:
(1) The port (food and) drug regulatory department refuses to issue the Notice of Import Drug Port Test in accordance with the provisions in Article 17 of the Provisions for Import Drug (Decree No. 4 of the State Food and Drug Administration and the General Administration of Customs);
(2) The port (food and) drug testing institute refuses the sampling in accordance with the requirements in Article 25 of the Provisions for Import Drug.
The port (food and) drug regulatory department shall take mandatory administrative measures to seal up or seize all the imported drugs within the situations prescribed in the previous paragraph. It shall make the decision of allowing shipping back within seven days from the date of the seal-up or seizure, and inform the importer of applying for the Export License for the drug according to the export procedures for anabolic agents and peptide hormones prescribed in the Provisions and return all the import drugs to the original exporting country.
Where the importer fails to respond or make clear its intention to ship back the drugs within ten days after being informed of the decision, the sealed up or seized drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Article 13 For imported anabolic agents and peptide hormones out of specifications upon testing by the port drug testing institute, the importer shall provide a detailed report about the distribution and use of all the imported drugs to the port (food and) drug regulatory department where the importer is located within two days after receiving the Import Drug Test Report.
After receiving the Import Drug Test Report, the port (food and) drug regulatory departments shall take mandatory administrative measures to timely seal up or seize all the drugs and, within seven days, decide whether or not to place the case on file.
Where the importer fails to apply for a retesting within the specified timeline or the result of the retesting is still out of specifications, the port (food and) drug regulatory department shall make the decision of allowing shipping back and notify the importer to apply for the Export License for the drug according to export procedures for anabolic agents and peptide hormones prescribed in the Provisions to return all the imported drugs to the original exporting country. Where the importer fails to respond or make clear its intention to ship back the drugs within ten days from the date of receiving the decision, the drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Where the result of retesting is in compliance with the specifications, the port (food and) drug regulatory department shall remove the mandatory administrative measures of seal-up and seizure.
The port (food and) drug regulatory department shall handle the case according to the provisions in Paragraph 2, Paragraph 3 and Paragraph 4 of this Article and report the result to the State Food and Drug Administration, and, at the same time, notify the (food and) drug regulatory departments of provinces, autonomous regions and municipalities directly under the Central Government as well as other port (food and) drug regulatory departments.
Article 14 Where domestic drug manufacturers, distributors and medical institutions purchase imported anabolic agents and peptide hormones, the supplier shall provide copies of the Import Drug License (or Pharmaceutical Product License), the Import License for the drug and the Import Drug Test Report, and affix its official seal to the abovementioned copies.
Article 15 The exporter shall apply for exportation of anabolic agents and peptide hormones to the (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government, where it is located, and submit the following materials:
(1) Application Form for Drug Export;
(2) Original import permit (or its copy with notarization) provided by the drug regulatory authority of the importing country or region.
If the importing country or region has no license system in the importation of anabolic agents and peptide hormones, the exporter shall provide the official document (original) of the drug regulatory authority of the importing country or region to prove that the import of the drugs of this type is exempted from the import permit, along with one of the following documents:
a. Original official document (or its copy with notarization) granting import provided by the drug regulatory authority of the importing country or region;
b. Certificates of legitimate qualifications of importers and original supporting document (or its copy with notarization) proving legitimate use of the drug;
(3) Copy of the purchasing contract or order form (except for manufacturers that export their own products);
(4) Copy of the export contract or order form;
(5) Where the export drug is an approved one produced by a domestic manufacturer, the Drug Manufacturing Certificate and Business License for Enterprises as a Legal Person of the manufacturer and a copy of the approval document of the drug shall be provided;
Where the export drug is produced by a domestic enterprise under contract of an overseas enterprise, the exporter shall provide a copy of the official document to prove recorded by the local (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government.
(6) Copies of the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the exporter.
All copies mentioned above should be stamped with the official seal of the exporter.
Article 16 Where the drugs are to be shipped back in accordance with the requirements in Article 12 and Article 13 of the Provisions, the exporter shall provide the following materials to apply for the Export License for the drug:
(1) Documents proving the request for return of goods made by the original exporter of the exporting country;
(2) Import License for the drug.
Article 17 The (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government shall decide whether or not to approve the export within 15 working days after receiving the export application and relevant materials.
Where the application is approved, the regulatory department shall issue the Export License for the drug; where the application is not approved, the regulatory department shall give reasons in writing.
Where the Export License for the drug is applied for in accordance with the requirements in Article 16 of the Provisions, the issuing authority shall mark “return of the original goods” on the Export License for the drug.
Article 18 The exporter may go through the customs formalities upon presenting the Export License for the drug issued by the (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government. The customs shall clear the drug in the presence of the Export License for the drug.
Article 19 The importer and exporter shall provide one more sheet of customs declaration form and apply for sign-back of the sheet when going through the customs formalities. The customs shall stamp the “proof seal” on the sheet in the presence of the Import License for the drug and Export License for the drug. The customs shall charge the cost according to the relevant regulations for issuing certificates.
The importer and exporter shall return the first sheet of the Import License for the drug or Export License for the drug along with the customs declaration form with the seal of the customs, to the issuing regulatory department within one month after completing the import and export.
Where the importer or exporter conducts no relevant importation or exportation after obtaining the Import License for the drug and Export License for the drug, the importer or exporter shall return the original license to the issuing regulatory department within one month after expiration of the license.
Article 20 The validation of the Import License for the drug is one year; the validation of the Export License for the drug is no more than three months (valid within the calendar year).
“One license for one customs clearance” is implemented for the Import License for the drug and Export License for the drug. The license shall be used only once within the validation and its content shall not be altered. Where the import or export is postponed for some reasons, the importer or exporter may request for a new license once with the original one.
Article 21 Where the Import License for the drug or Export License for the drug is lost, the importer or exporter shall report the loss to the original issuing authority in writing immediately. After receiving the loss report, the original issuing authority shall notify the port customs and reissue the license if no harmful consequences are found through confirmation.
Article 22 The Import License for the drug and Export License for the drug are uniformly printed by the State Food and Drug Administration.
Article 23 Where anabolic agents and peptide hormones are imported or exported in the form of processing trade, the customs shall go through and supervise the clearance formalities upon presentation of the Import License for the drug or Export License for the drug. Those not exported for special reasons shall be transferred to and handled by the local (food and) drug regulatory department in accordance with relevant regulations, and the customs shall conduct the verification and cancellation procedures in the presence of relevant documents.
Article 24 Anabolic agents and peptide hormones entering or leaving between bonded zones, export processing zones, other special Customs controlling areas, Customs bonded and controlling areas, with overseas, or between the special Customs controlling areas and the Customs bonded and controlling areas are exempt from application for the Import License for the drug or Export License for the drug, and supervised by the Customs.
Import License for the drug shall be applied for anabolic agents and peptide hormones entering from bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas into other places in China.
Export License for the drug shall be applied for anabolic agents and peptide hormones entering bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas from other places of China.
Article 25 Where an individual carries or mails anabolic agents and peptide hormones, within a reasonable amount, into or out of China for medical needs, the customs shall clear the drugs in the presence of prescriptions of medical institutions in accordance with relevant regulations on prescriptions of the competent health department.
Article 26 Besides prescribed in the Provisions, the importation, port test, supervision and control of anabolic agents and peptide hormones for medical purpose are implemented with reference to requirements related to drug importation in the Provisions for Drug Importation.
Article 27 Anabolic agents and peptide hormones imported for medical purpose mentioned in the Provisions refer to the import anabolic agents and peptide hormones to be used for preparation production or to be marketed in China.
Importer refers to the importer specified on the Import License for the drug obtained in accordance with the Provisions.
Exporter refers to the exporter specified on the Export License for the drug obtained in accordance with the Provisions.
Article 28 These Provisions shall go into effect as of September 1, 2006. The Notice on Import and Export of Anabolic Agents and Peptide Hormones (Guo Shi Yao Jian An [2004] No. 474) issued by the State Food and Drug Administration on September 30, 2004 shall be annulled therefrom.
